Plasma biomarkers in carbon monoxide poisoning

Clinical Toxicology

Volumn 48, Issue 1, 2010, Pages 47-56

  Thom, Stephen R ^a   Bhopale, Veena M ^a   Milovanova, Tatyana M ^a   Hardy, Kevin R ^a   Logue, Christopher J ^a   Lambert, David S ^a   Troxel, Andrea B ^b   Ballard, Kerri ^c   Eisinger, Dominic ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Rules Based Medicine   (United States)

Author keywords

Cytokines; Hyperbaric oxygen; Inflammatory markers; Smoke inhalation

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CARBOXYHEMOGLOBIN; CHEMOKINE; CYTOKINE; GROWTH FACTOR; HEMOGLOBIN; HORMONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CARBON MONOXIDE INTOXICATION; CONTROLLED STUDY; DISEASE SEVERITY; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LUNG BURN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARBON MONOXIDE POISONING; CARBOXYHEMOGLOBIN; CHEMOKINES; CYTOKINES; FEMALE; HORMONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKINS; MALE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; PILOT PROJECTS; SMOKE INHALATION INJURY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749083767     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650903468209     Document Type: Article

References (68)

1. Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning-a public health perspective. Toxicology 2000; 145:1-14.
2. Hampson NB, Weaver LK. Carbon monoxide poisoning: a new incidence for an old disease. Undersea Hyperb Med 2007; 34:163-168.
3. Arranz B, Blennow K, Eriksson A, Mansson JE, Marcusson J. Serotonergic, noradrenergic, and dopaminergic measures in suicide brains. Biol Psychiatry 1997; 41:1000-1009.
4. Ishimaru H, Katoh A, Suzuki H, Fukuta T, Kameyama T, Nabeshima T. Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxideinduced brain damage in mice. J Pharmacol Exp Therap 1992; 261:349-352.
5. Ishimaru H, Nabeshima T, Katoh A, Suzuki H, Fukuta T, Kameyama T. Effects of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal body temperature. Biochem Biophys Res Comm 1991; 179:836-840.
6. Nabeshima T, Katoh A, Ishimaru H, Yoneda Y, Ogita K, Murase K, Ohtsuka H, Inari K, Fukuta T, Kameyama T. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J Pharm Exp Therap 1991; 256:378-384.
7. Nabeshima T, Yoshida S, Morinaka H, Kameyama T, Thurkauf A, Rice KC, Jacobson AE, Monn JA, Cho AK. MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by CO. Neurosci Lett 1990; 108:321-327.
8. Newby MB, Roberts RJ, Bhatnagar RK. Carbon monoxide-and hypoxiainduced effects on catecholamines in the mature and developing rat brain. J Pharmacol Expt Therap 1978; 206:61-68.
9. Piantadosi CA, Zhang J, Demchenko IT. Production of hydroxyl radical in the hippocampus after CO hypoxia or hypoxic hypoxia in the rat. Free Radic Biol Med 1997; 22:725-732.
10. Liu Y, Fechter LD. MK-801 protects against carbon monoxide-induced hearing loss. Toxicol Appl Pharmacol 1995; 132:196-202.
11. Piantadosi CA, Carraway MS, Suliman HB. Carbon monoxide, oxidative stress and mitochondrial permeability pore transition. Free Radic Biol Med 2006; 40:1332-1339.
12. Thom SR, Bhopale V, Han S-T, Clark J, Hardy K. Intravascular neutrophil activation due to carbon monoxide poisoning. Am J Respir Crit Care Med 2006; 174:1239-1248.
13. Thom SR, Bhopale VM, Fisher D, Zhang J, Gimotty P. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci USA 2004; 101:13660-13665.
14. Mathieu D, Wattel F, Mathieu-Nolf M, Durak C, Tempe JP, Bouachour G, Sainty JM. Randomized prospective study comparing the effect of HBO versus 12 hours NBO in non-comatose CO poisoned patients. Undersea Hyperb Med 1996; 23(suppl):7.
15. Raphael JC, Elkharrat D, Guincestre MCJ, Chastang C, Vercken JB, Chasles V, Gajdos P. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; 2:414-419.
16. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25:474-480.
17. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, Orme JF, Jr, Thomas FO, Morris AH. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347:1057-1067.
18. Choi S. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983; 40:433-435.
19. Hampson NB. Emergency department visits for carbon monoxide poisoning in the Pacific Northwest. J Emerg Med 1998; 16:695-698.
20. Hampson NB, Hauff NM. Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture?. Am J Emerg Med 2008; 26:665-669.
21. Weaver LK, Valentine K, Hopkins R. Carbon monoxide poisoning: Risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 2007; 176:491-497.
22. Remick RA, Miles JE. Carbon monoxide poisoning: neurologic and psychiatric sequelae. Can Med Assoc J 1977; 117:654-657.
23. Ryan CM. Memory disturbances following chronic, low-level carbon monoxide exposure. Arch Clin Neuropsychol 1990; 5:59-67.
24. Davutoglu V, Gunay N, Kocoglu H, Gunay NE, Yildirim C, Cavdar M, Tarakcioglu M. Serum levels of NT-ProBNP as an early cardiac marker of carbon monoxide poisoning. Inhal Toxicol 2006; 18:155-158.
25. Kalay N, Ozdogru I, Cetinkaya Y, Eryol NK, Dogan A, Gul I, Inanc T, Ikizceli I, Oguzhan A, Abaci A. Cardiovascular effects of carbon monoxide poisoning. Am J Cardiol 2007; 99:322-324.
26. Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. J Am Med Assoc 2006; 295:398-402.
27. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005; 45:1513-1516.
28. Rasmussen LS, Poulsen MG, Christiansen M, Jansen EC. Biochemical markers for brain damage after carbon monoxide poisoning. Acta Anaesthesiol Scand 2004; 48:469-473.
29. Brvar M, Mozina H, Osredkar J, Mozina M, Noc M, Brucan A, Bunc M. S100B protein in carbon monoxide poisoning: a pilot study. Resuscitation 2004; 61:357-360.
30. Kim KM, Pae HO, Zheng M, Park R, Kim YM, Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 2007; 101:919-927.
31. Lee BS, Heo JH, Kim YM, Shim SM, Pae HO, Kim YM, Chung HT. Carbon monoxide mediates heme oxygenase-1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Commun 2006; 343:965-972.
32. Nakao A, Kaczorowski DJ, Zuckerbraun BS, Lei J, Faleo G, Deguchi K, McCurry KR, Billiar TR, Kanno S. Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. Biochem Biophys Res Commun 2008; 367:674-679.
33. Cronje FJ, Carraway MS, Freiberger JJ, Suliman HB, Piantadosi CA. Carbon monoxide actuates O(2)-limited heme degradation in the rat brain. Free Radic Biol Med 2004; 37:1802-1812.
34. Zuckerbraun BS, Billiar T, Otterbein SL, Kim PKM, Liu F, Choi AM, Bach FH, Otterbein L. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 2003; 198:1707-1716.
35. Maulik N, Engelman DT, Watanabe M, Engelman RM, Das DK. Nitric oxide a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem 1996; 157:75-86.
36. Brown SD, Piantadosi CA. Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J Clin Invest 1991; 89:666-672.
37. Thom SR, Ohnishi ST, Ischiropoulos H. Nitric oxide released by platelets inhibits neutrophil B2 integrin function following acute carbon monoxide poisoning. Toxicol Appl Pharmacol 1994; 128:105-110.
38. Thom SR, Xu YA, Ischiropoulos H. Vascular endothelial cells generate peroxynitrite in response to carbon monoxide exposure. Chem Res Toxicol 1997; 10:1023-1031.
39. Thom SR, Fisher D, Xu YA, Notarfrancesco K, Ischiropoulos H. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA 2000; 97:1305-1310.
40. Thom SR, Fisher D, Xu YA, Garner S, Ischiropoulos H. Role of nitric oxide-derived oxidants in vascular injury from carbon monoxide in the rat. Am J Physiol 1999; 276:H984-H992.
41. Thom SR, Ohnishi ST, Fisher D, Xu YA, Ischiropoulos H. Pulmonary vascular stress from carbon monoxide. Toxicol Appl Pharmacol 1999; 154:12-19.
42. Kjeldsen K, Astrup P, Wanstrup J. Ultrastructural intimal changes in the rabbit aorta after a moderate carbon monoxide exposure. Altherosclerosis 1972; 16:67-82.
43. Maurer FW. The effects of carbon monoxide anoxemia on the flow and composition of cervical lymph. Am J Physiol 1941; 133:170-179.
44. Parving HH, Ohlsson K, Buchardt-Hansen HJ, et al. Effect of carbon monoxide on capillary permeability to ablumin and macroglobulin. Scand J Clin Lab Invest 1972; 29:381-388.
45. Petersen FB, Siggaard-Anderson J, Kristensen JH, Kjeldsen K. Capillary filtration rate on the human calf during exposure to carbon monoxide and hypoxia (3454m). Scand J Clin Lab Invest 1968; 103:49-54.
46. Thom SR. Leukocytes in carbon monoxide-mediated brain oxidative injury. Toxicol Appl Pharmacol 1993; 123:234-247.
47. Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008; 45:562-569.
48. Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, Otterbein LE. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 2008; 86:267-279.
49. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 2003; 9:2525-2539.
50. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90:E17-E24.
51. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, Green CJ. CORM-A1: a new pharmacologically active carbon monoxidereleasing molecule. FASEB J 2005; 19:284-286.
52. Cepinskas G, Katada K, Bihari A, Potter RF. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol 2008; 294:G184-G191.
53. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-e8.
54. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653.
55. Ryter SW, Otterbein LE. Carbon monoxide in biology and medicine. BioEssays 2004; 26:270-280.
56. Wijayanti N, Huber S, Samoylenko A, Kietzmann T. Role of NF-kappaB and p38 MAP kinase signaling pathways in the lipopolysaccharidedependent activation of heme oxygenase-1 gene expression. Antioxid Redox Signal 2004; 6:802-810.
57. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7:598-604.
58. Mishra S, Fujita T, Lama VN, Nam D, Liao H, Okada M, Minamoto K, Yoshikawa Y, Harada H, Pinsky DJ. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci USA 2006; 103:5191-5196.
59. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, Otterbein SL, Otterbein LE, Choi AM. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003; 278:36993-36998.
60. Arruda MA, Rossi AG, de Freitas MS, Barja-Fidalgo C, Graça-Souza AV. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol 2004; 173:2023-2030.
61. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 2004; 172:3553-3563.
62. Scott JR, Chin BY, Bilban MH, Otterbein LE. Restoring HOmeostasis: is heme oxygenase-1 ready for the clinic? Trends Pharmacol Sci 2007; 28:200-205.
63. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 2006; 173:432-441. (Pubitemid 43228332)
64. Ruckerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T, Berglind N, Chrysohoou C, Forastiere F, Jacquemin B, von Klot S, Koenig W, Kuchenhoff H, Lanki T, Pekkanen J, Perucci CA, Schneider A, Sunyer J, Peters A. Air pollution and inflammation (interleukin-6, Creactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007; 115:1072-1080.
65. Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med 2000; 57:818-822.
66. Steinvil A, Kordova-Biezuner L, Shapira I, Berliner S, Rogowski O. Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res 2008; 106:51-61.
67. Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, Salomaa V. Association of criteria pollutants with plasma hemostatic/ inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol 2005; 15:319-328.
68. Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Giacomini S, Bonzini M, Lanzani G, Mannucci PM, Bertazzi PA, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. Effects of exposure to air pollution on blood coagulation. J Thromb Haemost 2007; 5:252-260.